LGR4 inhibitors belong to a specific chemical class of compounds that have been studied and designed to selectively target and inhibit the activity of LGR4, also known as Leucine-rich repeat-containing G protein-coupled receptor 4. LGR4 is a cell surface receptor that plays a role in various signaling pathways, including Wnt signaling and regulation of cell growth and development. Inhibition of LGR4 aims to disrupt its binding and signaling interactions with ligands, potentially modulating the downstream signaling cascades and cellular responses mediated by this receptor. The chemical structures of LGR4 inhibitors can vary, including synthetic small-molecule compounds and natural products that specifically interact with LGR4 and hinder its ligand recognition or G protein-coupled signaling.
Researchers have explored various strategies to target LGR4 and attenuate its effects on cellular signaling and biological processes. The study of LGR4 inhibitors provides valuable insights into the complex regulatory mechanisms governing cell growth and development, contributing to our understanding of cellular physiology and pathophysiology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $152.00 $515.00 | ||
Monensin is a natural antibiotic that has been explored for its inhibitory effects on LGR4 and LGR5. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $37.00 $77.00 $184.00 $510.00 $1224.00 $5814.00 | 8 | |
Niclosamide is an anthelmintic drug that has shown inhibitory effects on LGR4 and LGR5. | ||||||